Copenhagen, Denmark, and Ghent, Belgium, January 23, 2013 -- Hundreds of researchers and experts from all over the world are scheduled to convene in Ghent, Belgium, from June 25-28 for the 2013 International Conference on Genomics in Europe (ICG-Europe 2013). The conference, co-organized by BGI and VIB, will feature cutting-edge research, focusing on the latest developments in plant and animal genomics, metagenomics, as well as the the growing application of next-gen sequencing and advanced bioinformatics in the fields such as human diseases, biomedical research, and translational medicine.
The three-day conference will consist of 11 sessions featuring over 60 presentations. Included among the featured speakers will be scientists and university leaders, company directors, senior executives and CEOs from Belgium, Netherlands, Italy, Germany, U.S.A., Denmark, Australia, United Kingdom, France, China, etc . Ample networking opportunities are available for attendees to exchange views and discuss the latest advances and applications of Omics technologies. Researchers from around the globe are invited to attend ICG-2013.
Besides these sessions, two parallel workshops will be held at ICG Europe. The workshop "Innovation-Entrepreneurship in Venture Creation", will feature talks on launching spinout companies from research institutes, and will offer insights into VC and Pharma Venture arms view in investments in the genomics industry. The second workshop has a focus on ELSIs capturing the multi-dimensional issues and interrelationship among Environment, Health and Society.
It is the second time that BGI, the world largest genomic research organization, to bring Europe its acclaimed International Conference on Genomics (ICG). The first ICG-Europe was successfully conducted in Copenhagen, Denmark last May. "The past ICG Europe has achieved great success. This year we are excited to present the 2nd ICG Europe in Ghent." said Professor Huanming Yang, Chairman of BGI, "I believe it will provide an excellent opportunity for researchers, academia and industries to exchange ideas, share the latest findings and to form new collaborations in Genomics and related fields.
Professor Hans Galjaard, Chairman of the Department of Clinical Genetics at Erasmus University, Netherlands, said, "In 1983 I visited China for the first time as a member of a small U.N delegation to discuss human reproduction and preventive genetics. Remembering the facilities then available it is impressive how genomics research has developed to a high standard. Also from the beginning of this century public debates were organized about the psychosocial and ethical aspects of the new technologies. After previous successful ICG conferences in China, U.S.A and Europe from 2004 on, I am convinced that this present ICG conference will also be very fruitful. Are you seeking a strategic partner or external expertise to enhance your development, or are you looking to learn about the latest advance in genomics, discover how industry, academia and clinicians are collaborating to drive forward research and development, then we invite you to the three-day ICG conference in Ghent, tailor-made for you to explore the genomics world. "
ICG Europe 2013 will be held at Ghent University located in Ghent, a beautiful, cozy and ancient city in Belgium. Learn more information, please visit: http://www.
BGI was founded in Beijing, China, in 1999 with the mission to become a premier scientific partner for the global research community. The goal of BGI is to make leading-edge genomic science highly accessible, which it achieves through its investment in infrastructure, leveraging the best available technology, economies of scale, and expert bioinformatics resources. BGI, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications.
BGI has a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research: research that has generated over 200 publications in top-tier journals such as Nature and Science. BGI's many accomplishments include: sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, more recently, have sequenced the human Gut Metagenome, and a significant proportion of the genomes for the1000 Genomes Project.
For more information about BGI, please visit www.genomics.cn.
VIB is a life sciences research institutein Flanders, Belgium. With more than 1200 scientists from over 60 countries, we perform basic research into the molecular foundations of life. VIB is an excellence-based entrepreneurial institutethat focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications. VIB works in close partnership with four universities − UGent, K.U.Leuven, University of Antwerp and Vrije Universiteit Brussel, and is funded by the Flemish government. VIB develops and disseminates a wide range of science-based informationabout all aspects of biotechnology. For more information about VIB, please visit http://www.